Belay Diagnostics announced the publication of a new retrospective study demonstrating that its Summit and Vantage tests ...

Soligenix (NASDAQ: SNGX) announced that new supportive trial data for HyBryte(TM) in the treatment of cutaneous T-cell ...

Opdivo (nivolumab) has received approvals for two new indications in classical Hodgkin Lymphoma (cHL) from the US Food and ...

The U.S. Food and Drug Administration (FDA) on Friday approved a label expansion for Bristol Myers Squibb’s (BMY) antitumor therapy Opdivo to treat a blood cancer known as Hodgkin lymphoma as part of ...

Nivolumab plus AVD is now FDA-approved for previously untreated Stage III or IV classical Hodgkin lymphoma in patients aged 12 years and older.

FDA approval extends nivolumab into first-line stage III/IV cHL in adults and pediatrics, following priority review of the ...

Join the “New Developments in PCNSL Treatment” webinar to learn about new research, clinical trials, specialists, ...

WE all have that one friend who bathes in perfume before leaving the house, neck included, and we have learned to just wind ...

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination ...

She shared her cancer diagnosis with more than 18,000 social media followers and founded skin care brand Hermacy while ...

Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and ...